1100693
Takeda Pharmaceutical Company Limited — FEI 3002808311
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 9, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yodogawa-Ku (Japan)
Citations
| ID | CFR | Description |
| 1452 | 21 CFR 211.113(b) | Validation lacking for sterile drug products |
| 2031 | 21 CFR 211.194(a) | Complete test data included in records |
| 3572 | 21 CFR 211.100(b) | Procedure Deviations Recorded and Justified |
| 3603 | 21 CFR 211.160(b) | Scientifically sound laboratory controls |